| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Non-Hodgkin | 6 | 2020 | 1376 | 1.150 |
Why?
|
| Myocytes, Smooth Muscle | 10 | 2015 | 703 | 1.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 5 | 2015 | 696 | 0.610 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2012 | 1493 | 0.550 |
Why?
|
| Trachea | 10 | 2015 | 1095 | 0.520 |
Why?
|
| MAP Kinase Signaling System | 10 | 2020 | 1495 | 0.500 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2019 | 2297 | 0.480 |
Why?
|
| Hepatitis B virus | 2 | 2015 | 533 | 0.470 |
Why?
|
| Glucuronidase | 2 | 2015 | 205 | 0.470 |
Why?
|
| Fever of Unknown Origin | 1 | 2014 | 94 | 0.460 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2015 | 294 | 0.460 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 10 | 2015 | 478 | 0.460 |
Why?
|
| Preventive Health Services | 1 | 2018 | 570 | 0.440 |
Why?
|
| Hepatitis B | 3 | 2016 | 711 | 0.440 |
Why?
|
| Transcription Factor AP-1 | 2 | 2012 | 321 | 0.420 |
Why?
|
| Cyclooxygenase 2 | 5 | 2015 | 597 | 0.410 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2012 | 40 | 0.410 |
Why?
|
| NF-kappa B | 6 | 2015 | 2492 | 0.400 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2012 | 12 | 0.400 |
Why?
|
| Models, Educational | 1 | 2014 | 375 | 0.380 |
Why?
|
| Hematologic Diseases | 1 | 2014 | 498 | 0.360 |
Why?
|
| Antineoplastic Agents | 7 | 2016 | 13698 | 0.350 |
Why?
|
| Nephrology | 1 | 2014 | 270 | 0.350 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 12 | 2004 | 3810 | 0.350 |
Why?
|
| Kidney Diseases | 5 | 2014 | 2100 | 0.340 |
Why?
|
| Bradykinin | 3 | 2005 | 205 | 0.340 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 2149 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinases | 9 | 2010 | 1246 | 0.330 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2015 | 633 | 0.330 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 435 | 0.330 |
Why?
|
| Lymphoma, B-Cell | 2 | 2014 | 945 | 0.330 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2009 | 125 | 0.320 |
Why?
|
| Taiwan | 7 | 2015 | 524 | 0.310 |
Why?
|
| Thrombin | 3 | 2020 | 600 | 0.290 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 6 | 2015 | 1437 | 0.290 |
Why?
|
| Smoke | 1 | 2009 | 242 | 0.290 |
Why?
|
| src-Family Kinases | 2 | 2009 | 539 | 0.270 |
Why?
|
| Prognosis | 19 | 2020 | 30046 | 0.270 |
Why?
|
| Health Promotion | 1 | 2018 | 2210 | 0.270 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 873 | 0.260 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2493 | 0.260 |
Why?
|
| Heme Oxygenase-1 | 2 | 2020 | 364 | 0.260 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2006 | 121 | 0.250 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2015 | 2884 | 0.240 |
Why?
|
| Phospholipases A | 1 | 2005 | 204 | 0.240 |
Why?
|
| Lymphocyte Transfusion | 1 | 2006 | 232 | 0.240 |
Why?
|
| Mass Screening | 2 | 2018 | 5457 | 0.240 |
Why?
|
| Lipopolysaccharides | 4 | 2014 | 2222 | 0.240 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2015 | 692 | 0.240 |
Why?
|
| Bone Marrow | 1 | 2014 | 2936 | 0.230 |
Why?
|
| Astrocytes | 1 | 2012 | 1349 | 0.220 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2020 | 686 | 0.220 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2006 | 210 | 0.220 |
Why?
|
| Multiple Myeloma | 2 | 2012 | 5196 | 0.220 |
Why?
|
| Enzyme Induction | 4 | 2020 | 455 | 0.210 |
Why?
|
| Signal Transduction | 9 | 2015 | 23653 | 0.210 |
Why?
|
| Dinoprostone | 6 | 2015 | 597 | 0.210 |
Why?
|
| Kidney | 8 | 2019 | 7058 | 0.210 |
Why?
|
| Gene Expression Profiling | 9 | 2009 | 9549 | 0.200 |
Why?
|
| Cytosol | 1 | 2005 | 886 | 0.200 |
Why?
|
| Serum Response Factor | 2 | 2012 | 78 | 0.200 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 160 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2003 | 269 | 0.190 |
Why?
|
| Cytokines | 2 | 2016 | 7453 | 0.190 |
Why?
|
| Cells, Cultured | 19 | 2015 | 19023 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2020 | 693 | 0.190 |
Why?
|
| DNA Fingerprinting | 2 | 2002 | 114 | 0.180 |
Why?
|
| Flavones | 1 | 2020 | 66 | 0.180 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2020 | 91 | 0.180 |
Why?
|
| Aged, 80 and over | 19 | 2020 | 59739 | 0.180 |
Why?
|
| Acute Kidney Injury | 4 | 2016 | 1936 | 0.170 |
Why?
|
| Philadelphia Chromosome | 1 | 2020 | 119 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2015 | 2460 | 0.170 |
Why?
|
| Cyclin G1 | 1 | 2019 | 15 | 0.160 |
Why?
|
| Bone Marrow Transplantation | 2 | 2006 | 2709 | 0.160 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 3 | 2004 | 318 | 0.150 |
Why?
|
| Cell Compartmentation | 1 | 2019 | 383 | 0.150 |
Why?
|
| Databases, Genetic | 2 | 2002 | 1758 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 379 | 0.150 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2020 | 430 | 0.150 |
Why?
|
| Organ Specificity | 2 | 2002 | 1970 | 0.150 |
Why?
|
| Trans-Activators | 3 | 2012 | 2858 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 7 | 2014 | 474 | 0.140 |
Why?
|
| Protein Kinase C | 6 | 2009 | 1207 | 0.140 |
Why?
|
| Transfection | 4 | 2015 | 5763 | 0.140 |
Why?
|
| Enzyme Inhibitors | 10 | 2015 | 3726 | 0.140 |
Why?
|
| Isoenzymes | 4 | 2011 | 1687 | 0.130 |
Why?
|
| Aorta | 2 | 2015 | 2046 | 0.130 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2015 | 38 | 0.130 |
Why?
|
| Up-Regulation | 5 | 2012 | 4148 | 0.130 |
Why?
|
| Aged | 26 | 2020 | 171786 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2016 | 234 | 0.120 |
Why?
|
| Ferrosoferric Oxide | 1 | 2016 | 348 | 0.120 |
Why?
|
| Lymphocyte Count | 2 | 2014 | 794 | 0.120 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 148 | 0.120 |
Why?
|
| Middle Aged | 27 | 2020 | 223737 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2014 | 4356 | 0.110 |
Why?
|
| Phosphorylation | 9 | 2015 | 8317 | 0.110 |
Why?
|
| Humans | 63 | 2020 | 768970 | 0.110 |
Why?
|
| Peripheral Nerves | 3 | 1993 | 492 | 0.110 |
Why?
|
| Training Support | 1 | 2014 | 109 | 0.110 |
Why?
|
| Schwann Cells | 2 | 1993 | 196 | 0.110 |
Why?
|
| Endothelin-1 | 1 | 2015 | 296 | 0.110 |
Why?
|
| Cell Line | 7 | 2020 | 15604 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2011 | 412 | 0.110 |
Why?
|
| Neurofibroma | 2 | 1991 | 95 | 0.110 |
Why?
|
| Transcriptional Activation | 3 | 2015 | 1750 | 0.110 |
Why?
|
| Fibroblasts | 3 | 2020 | 4179 | 0.110 |
Why?
|
| Male | 39 | 2020 | 365203 | 0.110 |
Why?
|
| Connective Tissue | 2 | 1993 | 425 | 0.110 |
Why?
|
| Gene Expression | 4 | 2015 | 7603 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2014 | 178 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2012 | 287 | 0.100 |
Why?
|
| Virus Activation | 1 | 2015 | 324 | 0.100 |
Why?
|
| Cisplatin | 2 | 2016 | 1661 | 0.100 |
Why?
|
| Cardiomegaly | 1 | 2015 | 591 | 0.100 |
Why?
|
| Community-Institutional Relations | 1 | 2014 | 209 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6569 | 0.100 |
Why?
|
| Nervous System Neoplasms | 1 | 1993 | 91 | 0.100 |
Why?
|
| Smoking | 1 | 2009 | 9094 | 0.100 |
Why?
|
| Epithelial Cells | 4 | 2019 | 3702 | 0.100 |
Why?
|
| Nuclear Proteins | 3 | 2012 | 5804 | 0.100 |
Why?
|
| RNA Interference | 4 | 2015 | 2835 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 7 | 2020 | 11886 | 0.100 |
Why?
|
| Quercetin | 1 | 2012 | 97 | 0.100 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 874 | 0.100 |
Why?
|
| Interleukin-4 | 1 | 2016 | 1157 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2015 | 556 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2015 | 648 | 0.100 |
Why?
|
| RNA, Small Interfering | 5 | 2014 | 3433 | 0.100 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 133 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2010 | 637 | 0.100 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2014 | 240 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15471 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2015 | 462 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2063 | 0.090 |
Why?
|
| Heat-Shock Response | 1 | 2012 | 179 | 0.090 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 930 | 0.090 |
Why?
|
| Laminin | 1 | 1993 | 406 | 0.090 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2011 | 176 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2012 | 581 | 0.090 |
Why?
|
| Pertussis Toxin | 7 | 2004 | 176 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 2015 | 1149 | 0.090 |
Why?
|
| Adult | 23 | 2020 | 223851 | 0.090 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2012 | 263 | 0.090 |
Why?
|
| Immunoblastic Lymphadenopathy | 1 | 2010 | 40 | 0.090 |
Why?
|
| Female | 34 | 2020 | 397515 | 0.090 |
Why?
|
| Estrenes | 3 | 2005 | 21 | 0.090 |
Why?
|
| Autophagy | 1 | 2019 | 1351 | 0.090 |
Why?
|
| Computational Biology | 2 | 2002 | 3562 | 0.090 |
Why?
|
| Retrospective Studies | 13 | 2020 | 81903 | 0.090 |
Why?
|
| Rhabdomyolysis | 1 | 2011 | 150 | 0.090 |
Why?
|
| Erythrocyte Membrane | 2 | 1991 | 438 | 0.090 |
Why?
|
| Vincristine | 4 | 2013 | 1040 | 0.090 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 11262 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 796 | 0.090 |
Why?
|
| Pyrrolidinones | 3 | 2005 | 116 | 0.080 |
Why?
|
| Lymphopenia | 1 | 2012 | 300 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 1991 | 252 | 0.080 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2010 | 103 | 0.080 |
Why?
|
| Haplotypes | 1 | 2016 | 2725 | 0.080 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 361 | 0.080 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2014 | 246 | 0.080 |
Why?
|
| Survival Analysis | 6 | 2012 | 10115 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 113 | 0.080 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2009 | 101 | 0.080 |
Why?
|
| Survival Rate | 6 | 2020 | 12873 | 0.080 |
Why?
|
| Lymphocytes | 2 | 2015 | 2614 | 0.080 |
Why?
|
| DNA | 4 | 2003 | 7214 | 0.080 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2009 | 178 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2015 | 1530 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 115 | 0.080 |
Why?
|
| Dogs | 5 | 2005 | 3845 | 0.080 |
Why?
|
| Neurilemmoma | 2 | 1991 | 524 | 0.080 |
Why?
|
| Wound Healing | 2 | 2019 | 2815 | 0.080 |
Why?
|
| Muscle Weakness | 1 | 2011 | 413 | 0.080 |
Why?
|
| Mentors | 1 | 2014 | 672 | 0.080 |
Why?
|
| RNA, Messenger | 6 | 2012 | 12806 | 0.080 |
Why?
|
| Genistein | 2 | 2005 | 87 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2339 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12253 | 0.070 |
Why?
|
| Lymphoma, T-Cell | 1 | 2010 | 308 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2011 | 533 | 0.070 |
Why?
|
| Prednisone | 4 | 2013 | 1567 | 0.070 |
Why?
|
| Anemia | 1 | 2017 | 1517 | 0.070 |
Why?
|
| Career Choice | 1 | 2014 | 769 | 0.070 |
Why?
|
| Myocardium | 1 | 2020 | 4790 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 8664 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1248 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2006 | 5864 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2009 | 368 | 0.070 |
Why?
|
| LLC-PK1 Cells | 2 | 2019 | 125 | 0.070 |
Why?
|
| Phospholipids | 1 | 1991 | 787 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 1169 | 0.070 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2009 | 207 | 0.070 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2004 | 24 | 0.070 |
Why?
|
| Cyclophosphamide | 4 | 2013 | 2227 | 0.070 |
Why?
|
| Animals | 26 | 2019 | 169335 | 0.070 |
Why?
|
| Protein Phosphatase 2 | 1 | 2008 | 231 | 0.070 |
Why?
|
| Synovial Membrane | 1 | 2010 | 536 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 1682 | 0.070 |
Why?
|
| Leukapheresis | 1 | 2007 | 150 | 0.070 |
Why?
|
| Mesothelioma | 2 | 2003 | 811 | 0.070 |
Why?
|
| Integrins | 1 | 1991 | 843 | 0.070 |
Why?
|
| Models, Biological | 3 | 2013 | 9499 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2016 | 6346 | 0.070 |
Why?
|
| Norbornanes | 1 | 2005 | 10 | 0.070 |
Why?
|
| Leukemic Infiltration | 1 | 2006 | 47 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2683 | 0.070 |
Why?
|
| Thiocarbamates | 1 | 2005 | 30 | 0.070 |
Why?
|
| Thiones | 1 | 2005 | 51 | 0.060 |
Why?
|
| Doxorubicin | 4 | 2013 | 2234 | 0.060 |
Why?
|
| Thalidomide | 1 | 2011 | 886 | 0.060 |
Why?
|
| Microfluidics | 1 | 2011 | 674 | 0.060 |
Why?
|
| Phospholipases A2 | 1 | 2005 | 197 | 0.060 |
Why?
|
| Cell Separation | 1 | 2011 | 1728 | 0.060 |
Why?
|
| World Health Organization | 1 | 2011 | 1328 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2010 | 888 | 0.060 |
Why?
|
| Monocytes | 1 | 2015 | 2603 | 0.060 |
Why?
|
| Cell Division | 5 | 2004 | 4478 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2019 | 385 | 0.060 |
Why?
|
| Recurrence | 2 | 2016 | 8513 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2003 | 205 | 0.060 |
Why?
|
| Rats | 4 | 2012 | 23786 | 0.060 |
Why?
|
| Brain | 1 | 2012 | 27453 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2010 | 1655 | 0.060 |
Why?
|
| Reperfusion Injury | 3 | 2015 | 1036 | 0.060 |
Why?
|
| Dermis | 1 | 2006 | 203 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2007 | 656 | 0.060 |
Why?
|
| Plasmodium falciparum | 2 | 1991 | 1741 | 0.060 |
Why?
|
| Histocompatibility Testing | 1 | 2006 | 716 | 0.060 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2004 | 67 | 0.060 |
Why?
|
| Genes, Immunoglobulin | 1 | 2005 | 286 | 0.060 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 251 | 0.060 |
Why?
|
| Young Adult | 10 | 2020 | 60131 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 4056 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 2228 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5707 | 0.050 |
Why?
|
| Algorithms | 3 | 2014 | 14201 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2005 | 454 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2012 | 10486 | 0.050 |
Why?
|
| Epidermis | 1 | 2006 | 539 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 3713 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2010 | 2336 | 0.050 |
Why?
|
| RNA | 2 | 2011 | 2727 | 0.050 |
Why?
|
| Contrast Media | 1 | 2016 | 5334 | 0.050 |
Why?
|
| Pregnancy Proteins | 1 | 2003 | 222 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 15879 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5342 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 8144 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 39394 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4528 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2002 | 1305 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2422 | 0.050 |
Why?
|
| Reference Values | 3 | 2001 | 4940 | 0.050 |
Why?
|
| Type C Phospholipases | 4 | 2002 | 287 | 0.050 |
Why?
|
| Substance P | 1 | 2002 | 332 | 0.050 |
Why?
|
| Radiation Chimera | 2 | 2015 | 216 | 0.050 |
Why?
|
| Calcium | 5 | 2005 | 5792 | 0.050 |
Why?
|
| Mutation | 3 | 2020 | 30266 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2012 | 22296 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 24333 | 0.040 |
Why?
|
| Calcium Signaling | 2 | 2002 | 738 | 0.040 |
Why?
|
| Cholera Toxin | 4 | 2003 | 562 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 21547 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2003 | 643 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2179 | 0.040 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 11932 | 0.040 |
Why?
|
| Hospitals, Veterans | 2 | 2012 | 395 | 0.040 |
Why?
|
| Transcription Factors | 4 | 2009 | 12174 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 6856 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 1148 | 0.040 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 4363 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2015 | 7885 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2004 | 876 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 3110 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 2565 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 1064 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1993 | 2474 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 931 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 5831 | 0.040 |
Why?
|
| Quality Control | 1 | 2002 | 836 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 2812 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1251 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2002 | 563 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 6547 | 0.040 |
Why?
|
| Leukocytes | 1 | 2007 | 2034 | 0.040 |
Why?
|
| Epithelium, Corneal | 1 | 2001 | 247 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 1990 | 0.040 |
Why?
|
| Lung Neoplasms | 3 | 2009 | 13594 | 0.040 |
Why?
|
| Mice | 12 | 2019 | 82072 | 0.040 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 124 | 0.040 |
Why?
|
| Risk Factors | 4 | 2020 | 74976 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1999 | 154 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2002 | 508 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2012 | 6435 | 0.040 |
Why?
|
| Adolescent | 9 | 2020 | 89244 | 0.040 |
Why?
|
| Pleural Neoplasms | 1 | 2002 | 612 | 0.040 |
Why?
|
| Phenotype | 3 | 2012 | 16731 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 4835 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 2010 | 9264 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2007 | 3408 | 0.040 |
Why?
|
| Enzyme Activation | 4 | 2004 | 3588 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 395 | 0.030 |
Why?
|
| Protein Binding | 1 | 2009 | 9344 | 0.030 |
Why?
|
| Remission Induction | 2 | 2014 | 2408 | 0.030 |
Why?
|
| Swine | 2 | 2019 | 5997 | 0.030 |
Why?
|
| Salvage Therapy | 2 | 2014 | 1277 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 8559 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 4978 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 16053 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3813 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2015 | 835 | 0.030 |
Why?
|
| Disease Progression | 3 | 2020 | 13674 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 200 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 2 | 1993 | 316 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 1560 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2001 | 2732 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 5892 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2002 | 1495 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2015 | 350 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4251 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2004 | 3449 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3780 | 0.030 |
Why?
|
| Premedication | 1 | 2015 | 246 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2002 | 1769 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2014 | 188 | 0.030 |
Why?
|
| Dactinomycin | 1 | 2014 | 305 | 0.030 |
Why?
|
| Cycloheximide | 1 | 2014 | 341 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2014 | 363 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2006 | 3048 | 0.030 |
Why?
|
| Connective Tissue Cells | 1 | 1993 | 50 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4785 | 0.030 |
Why?
|
| Isomerism | 1 | 1993 | 198 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 257 | 0.030 |
Why?
|
| Thymidine | 2 | 2003 | 297 | 0.030 |
Why?
|
| Internet | 2 | 2002 | 3112 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 1056 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2014 | 386 | 0.030 |
Why?
|
| Splenectomy | 1 | 2014 | 392 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 440 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 2 | 2002 | 154 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 4592 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3608 | 0.020 |
Why?
|
| Benzamides | 1 | 2017 | 1387 | 0.020 |
Why?
|
| Fibrosis | 1 | 2019 | 2080 | 0.020 |
Why?
|
| Glutamate Dehydrogenase | 1 | 1991 | 50 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2006 | 10276 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 877 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 1991 | 151 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 271 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 1991 | 182 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2015 | 1609 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 11116 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36854 | 0.020 |
Why?
|
| Asthma | 4 | 2015 | 6293 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4413 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1991 | 247 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2011 | 2942 | 0.020 |
Why?
|
| Acidosis, Lactic | 1 | 2011 | 145 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1917 | 0.020 |
Why?
|
| Genetic Variation | 2 | 2004 | 6611 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2009 | 63 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 1798 | 0.020 |
Why?
|
| Epitopes | 2 | 1993 | 2529 | 0.020 |
Why?
|
| Spermatozoa | 1 | 1993 | 632 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2017 | 65480 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2009 | 97 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2008 | 67 | 0.020 |
Why?
|
| Genome, Human | 1 | 2002 | 4456 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1993 | 2298 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 863 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10765 | 0.020 |
Why?
|
| Antigens | 1 | 1993 | 1444 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3775 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18354 | 0.020 |
Why?
|
| Actins | 1 | 2015 | 2065 | 0.020 |
Why?
|
| Protein Isoforms | 2 | 2003 | 1714 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2009 | 199 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1658 | 0.020 |
Why?
|
| Time Factors | 4 | 2015 | 40261 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1614 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2012 | 810 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2126 | 0.020 |
Why?
|
| Inflammation | 3 | 2015 | 10868 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 1966 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 342 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1794 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1751 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2012 | 1793 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9618 | 0.020 |
Why?
|
| Liver | 1 | 2002 | 7578 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1991 | 1191 | 0.020 |
Why?
|
| United States | 1 | 2014 | 73186 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 22379 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2009 | 583 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2431 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2016 | 4199 | 0.020 |
Why?
|
| Fetus | 1 | 1993 | 1882 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1991 | 1110 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1608 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12562 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1780 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 6401 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2008 | 1524 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2005 | 777 | 0.010 |
Why?
|
| Placenta | 1 | 1993 | 1725 | 0.010 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2009 | 542 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2004 | 98 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1395 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 1251 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2009 | 1153 | 0.010 |
Why?
|
| Rabbits | 2 | 2004 | 4774 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2009 | 951 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2010 | 1505 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 2433 | 0.010 |
Why?
|
| Lung | 1 | 2002 | 10099 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3102 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18435 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1991 | 1812 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1111 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2015 | 3080 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1833 | 0.010 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2002 | 20 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2002 | 222 | 0.010 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2002 | 29 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3070 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2009 | 1611 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1991 | 2421 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 210 | 0.010 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 93 | 0.010 |
Why?
|
| Sirolimus | 1 | 2009 | 1540 | 0.010 |
Why?
|
| Collagen | 1 | 1990 | 2646 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2001 | 102 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 312 | 0.010 |
Why?
|
| Proteomics | 1 | 2015 | 3914 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 250 | 0.010 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 20245 | 0.010 |
Why?
|
| Pneumonia | 2 | 2002 | 2164 | 0.010 |
Why?
|
| Database Management Systems | 1 | 2002 | 263 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 751 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 331 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 17173 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2002 | 344 | 0.010 |
Why?
|
| Growth Substances | 1 | 2002 | 760 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2067 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14484 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6086 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9527 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1999 | 229 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2909 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2002 | 764 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2001 | 691 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2003 | 1337 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2269 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15951 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 22389 | 0.010 |
Why?
|
| Benchmarking | 1 | 2004 | 1059 | 0.010 |
Why?
|
| ras Proteins | 1 | 2003 | 1058 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 3076 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 1083 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 2003 | 1091 | 0.010 |
Why?
|
| Ischemia | 1 | 2005 | 1900 | 0.010 |
Why?
|
| Regeneration | 1 | 2005 | 1524 | 0.010 |
Why?
|
| Information Storage and Retrieval | 1 | 2002 | 831 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 1625 | 0.010 |
Why?
|
| Neurons | 1 | 2015 | 9519 | 0.010 |
Why?
|
| Drug Design | 1 | 2001 | 1046 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6512 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 5033 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6673 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 1169 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6236 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6332 | 0.010 |
Why?
|
| Sperm-Ovum Interactions | 1 | 1993 | 24 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 6011 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1993 | 256 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 2945 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 9565 | 0.010 |
Why?
|
| Staphylococcal Protein A | 1 | 1991 | 39 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1993 | 828 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1993 | 2173 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1991 | 235 | 0.010 |
Why?
|
| Rhodamines | 1 | 1991 | 178 | 0.010 |
Why?
|
| Fluorescein | 1 | 1991 | 175 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 4794 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12095 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 41808 | 0.010 |
Why?
|
| Cricetinae | 1 | 1993 | 2423 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7609 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 5110 | 0.010 |
Why?
|
| Dextrans | 1 | 1991 | 574 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1999 | 1595 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14752 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 13021 | 0.000 |
Why?
|
| Endocytosis | 1 | 1991 | 959 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1993 | 6232 | 0.000 |
Why?
|
| Logistic Models | 1 | 1999 | 13318 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2002 | 11684 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1991 | 2635 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1991 | 1933 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1991 | 3659 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4568 | 0.000 |
Why?
|
| Child | 1 | 2005 | 80960 | 0.000 |
Why?
|
| Skin | 1 | 1990 | 4506 | 0.000 |
Why?
|
| Pregnancy | 1 | 1993 | 30265 | 0.000 |
Why?
|